Expanded Outpatient Programs and New Culturally Specific Recovery Support Increase Statewide Access to Treatment Kai Shin Clinic is expanding access to evidence-based addiction treatment services at its Bloomington location and is now accepting new patients across all outpatient levels of care. This update increases reachability for Minnesotans seeking integrated addiction treatment grounded in clinical excellence, […]

NEW YORK, NY / ACCESS Newswire / December 18, 2025 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Primo Brands Corporation / Primo Water Corporation (NYSE:PRMB) securities. If you suffered a loss on your Primo Brands Corporation / Primo

NEW YORK, NY / ACCESS Newswire / December 18, 2025 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Avantor, Inc. (NYSE:AVTR) securities. If you suffered a loss on your Avantor, Inc. investment and would like to explore a potential

Strategic transaction crystallizes the brand’s substantial value creating opportunity to accelerate growth Fully de-levers WildBrain’s balance sheet, eliminating all debt and saving approximately $50 million in annual interest payments and leaving over $40 million cash surplus Allows reinvestment in high-growth, cash-accretive opportunities across wholly owned franchises, premium digital network, and innovative technologies WildBrain retained by

All FlavorsContain Zero Added Sugar and Only Real-Food Ingredients Laird Superfood®, Inc. (NYSE: LSF), a leader in functional coffee, creamers, and superfood products made with simple, minimally processed ingredients, has expanded its Hydrate linewith two new flavors. Wild Berrycontains a blend of antioxidant-rich maqui, calafate and murta berries from Patagonia; Tropical Punchoffers a blend of

(TSE:4565.T), Tokyo, Japan and Cambridge, UK, 19 December 2025 – Nxera Pharma Co. Ltd (“Nxera” or “the Company; TSE 4565) today announces that Boehringer Ingelheim has informed the Company of its decision not to exercise its exclusive option to license Nxera's GPR52 agonist program for schizophrenia, including the Phase 2 ready lead compound NXE0048149 (“NXE'149”).

Nxera Pharma to Regain Full Rights to GPR52 Agonist Program for Schizophrenia GlobeNewswire December 18, 2025 Tokyo, Japan and Cambridge, UK, 19 December 2025 – Nxera Pharma Co. Ltd (“Nxera” or “the Company; TSE 4565) today announces that Boehringer Ingelheim has informed the Company of its decision not to exercise its exclusive option to license

NEW YORK, NY / ACCESS Newswire / December 18, 2025 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired DeFi Technologies (NASDAQ:DEFT) securities. If you suffered a loss on your DeFi Technologies investment and would like to explore a potential

NEW YORK, NY / ACCESS Newswire / December 18, 2025 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Firefly Aerospace Inc. (NASDAQ:FLY) securities. If you suffered a loss on your Firefly Aerospace Inc. investment and would like to explore

(TSX-V:SCAN),(OTC US:LDDFF),(Other OTC:LDDFF),(Boerse Frankfurt – Freiverkehr:E30),(Boerse Frankfurt – Freiverkehr:LD2A), NOT FOR DISTRIBUTION TO U.S. NEWSWIRES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia and WILMINGTON, Mass., Dec. 18, 2025 (GLOBE NEWSWIRE) — Liberty Defense Holdings Ltd. (“Liberty” or the “Company“) (TSXV: SCAN, OTCQB: LDDFF, FRANKFURT: LD2), a leading technology provider of AI-based next generation